Aberrant expression of disintegrin-metalloprotease proteins in the formation and progression of uterine cervical cancer

Pathobiology

Volumn 78, Issue 3, 2011, Pages 149-161

  Shaker, Mohammed ^a,b   Yokoyama, Yuhki ^a   Mori, Seiji ^a   Tsujimoto, Masahiko ^d   Kawaguchi, Naomasa ^a   Kiyono, Tohru ^c   Nakano, Toru ^b   Matsuura, Nariaki ^a  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b OSAKA UNIVERSITY   (Japan)

^c NATIONAL CANCER CENTER RESEARCH INSTITUTE   (Japan)

^d OSAKA POLICE HOSPITAL   (Japan)

Author keywords

ADAM; ADAMTS; Cervical intraepithelial neoplasia; Cervix; Disintegrin; Tissue inhibitor of metalloprotease

Indexed keywords

ADAM PROTEIN; ADAM10 ENDOPEPTIDASE; MESSENGER RNA; PROTEIN ADAM 12; PROTEIN ADAM 9; PROTEIN E6; PROTEIN E7; TISSUE INHIBITOR OF METALLOPROTEINASE; TISSUE INHIBITOR OF METALLOPROTEINASE 2; TISSUE INHIBITOR OF METALLOPROTEINASE 3; UNCLASSIFIED DRUG;

ARTICLE; CANCER CELL; CANCER GROWTH; CANCER INVASION; CELL IMMORTALIZATION; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN TISSUE; KERATINOCYTE; ONCOGENE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR UPREGULATION; UTERINE CERVIX CANCER;

ADAM PROTEINS; BLOTTING, WESTERN; CELL LINE, TUMOR; CERVICAL INTRAEPITHELIAL NEOPLASIA; CERVIX UTERI; DISEASE PROGRESSION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; NEOPLASM PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TISSUE INHIBITOR OF METALLOPROTEINASES; UTERINE CERVICAL NEOPLASMS;

HUMAN PAPILLOMAVIRUS;

EID: 80955175361     PISSN: 10152008     EISSN: 14230291     Source Type: Journal    
DOI: 10.1159/000324314     Document Type: Article

References (52)

1. Thun MJ, DeLancey JO, Center MM, Jemal A, Ward EM: The global burden of cancer: priorities for prevention. Carcinogenesis 2010;31:100-110.
2. Stoler MH: Human papillomaviruses and cervical neoplasia: a model for carcinogenesis. Int J Gynecol Pathol 2000; 19:16-28. (Pubitemid 30010639)
3. Münger K, Baldwin A, Edwards KM, Hayakawa H, Nguyen CL, Owens M, Grace M, Huh K: Mechanisms of human papillomavi-rus-induced oncogenesis. J Virol 2004; 78: 11451-11460.
4. zur Hausen H: Papillomaviruses and cancer: from basic studies to clinical application. Nat Rev Cancer 2002;2:342-350. (Pubitemid 37328947)
5. Wolfsberg TG, Primakoff P, Myles DG, White JM: ADAM, a novel family of membrane proteins containing A Disintegrin And Metalloprotease domain: multipotential functions in cell-cell and cell-matrix interactions. J Cell Biol 1995;131:275-278.
6. Jones GC, Riley GP: ADAMTS proteinases: a multi-domain, multi-functional family with roles in extracellular matrix turnover and arthritis. Arthritis Res Ther 2005;7:160-169. (Pubitemid 40936607)
7. Van Goor H, Melenhorst WB, Turner AJ, Holgate ST: Adamalysins in biology and disease. J Pathol 2009;219:277-286.
8. Higuchi Y, Yasui A, Matsuura K, Yamamoto S: CD156 transgenic mice. Different responses between inflammatory types. Pathobiology 2002;70:47-54. (Pubitemid 36151553)
9. Shiomi T, Lemaître V, D'Armiento J, Okada Y: Matrix metalloproteinases, a disintegrin and metalloproteinases, and a disintegrin and metalloproteinases with thrombospon-din motifs in non-neoplastic diseases. Pathol Int 2010;60:477-496.
10. Eto K, Huet C, Tarui T, Kupriyanov S, Liu HZ, Puzon-McLaughlin W, Zhang XP, Sheppard D, Engvall E, Takada Y: Functional classification of ADAMs based on a conserved motif for binding to integrin alpha 9 betal: implications for sperm-egg binding and other cell interactions. J Biol Chem 2002; 277:17804-17810. (Pubitemid 34967588)
11. Yang P, Baker KA, Hagg T: The ADAM s family: coordinators of nervous system development, plasticity and repair. Prog Neurobiol 2006;79:73-94. (Pubitemid 44247280)
12. Gilpin BJ, Loechel F, Mattei MG, Engvall E, Albrechtsen R, Wewer UM: A novel, secreted form of human ADAM 12 (meltrin alpha) provokes myogenesis in vivo. J Biol Chem 1998;273:157-166. (Pubitemid 28042189)
13. Kawaguchi N, Xu X, Tajima R, Kronqvist P, Sundberg C, Loechel F, Albrechtsen R, Wewer UM: ADAM 12 protease induces adipo-genesis in transgenic mice. Am J Pathol 2002;160:1895-1903. (Pubitemid 34525669)
14. Duffy MJ, McKiernan E, O'Donovan N, McGowan PM: Role of ADAMs in cancer formation and progression. Clin Cancer Res 2009;15:1140-1144.
15. Mochizuki S, Okada Y: ADAMs in cancer cell proliferation and progression. Cancer Sei 2007;98:621-628. (Pubitemid 46563436)
16. Apte SS: A disintegrin-like and metallopro-tease (reprolysin-type) with thrombospon-din type 1 motif (ADAMTS) superfamily: functions and mechanisms. J Biol Chem 2009;284:31493-31497.
17. Liu YJ, Xu Y, Yu Q: Full-length ADAMTS-1 and the ADAMTS-1 fragments display pro-and antimetastatic activity, respectively. Oncogene 2006;25:2452-2467.
18. Rocks N, Paulissen G, El Hour M, Quesada F, Crahay C, Gueders M, Foidart JM, Noel A, Cataldo D: Emerging roles of ADAM and ADAMTS metalloproteinases in cancer. Biochimie 2008;90:369-379. (Pubitemid 351172571)
19. Murphy G: The ADAMs: signalling scissors in the tumour microenvironment. Nat Rev Cancer 2008;8:929-941.
20. Maskos K, Fernandez-Catalan C, Huber R, Bourenkov GP, Bartunik H, Ellestad GA, Reddy P, Wolfson MF, Rauch CT, Castner BJ, Davis R, Clarke HR, Petersen M, Fitzner JN, Cerretti DP, March CJ, Paxton RJ, Black RA, Bode W: Crystal structure of the catalytic domain of human tumor necrosis factor-alpha-converting enzyme. Proc Natl Acad Sei USA 1998;95:3408-3412. (Pubitemid 28173141)
21. Brew K, Dinakarpandian D, Nagase H: Tissue inhibitors of metalloproteinases: evolution, structure and function. Biochim Biophys Acta 2000; 1477:267-283. (Pubitemid 30119906)
22. Amour A, Knight CG, Webster A, Slocombe PM, Stephens PE, Knäuper V, Docherty AJ, Murphy G: The in vitro activity of ADAM-10 is inhibited by TIMP-1 and TIMP-3. FEBS Lett 2000;473:275-279. (Pubitemid 30249139)
23. Kashiwagi M, Tortorella M, Nagase H, Brew K: TIMP-3 is a potent inhibitor of aggrecanase 1 (ADAM-TS4) and aggrecanase 2 (ADAM-TS5). J Biol Chem 2001;276:12501-12504.
24. Hanahan D, Weinberg RA: The hallmarks of cancer. Cell 2000;100:57-70. (Pubitemid 30046295)
25. Sheu BC, Lien HC, Ho HN, Lin HH, Chow SN, Huang SC, Hsu SM: Increased expression and activation of gelatinolytic matrix metalloproteinases is associated with the progression and recurrence of human cervical cancer. Cancer Res 2003;63:6537-6542.
26. Libra M, Scalisi A, Vella N, Clementi S, Sorio R, Stivala F, Spandidos DA, Mazzarino C: Uterine cervical carcinoma: role of matrix metalloproteinases. Int J Oncol 2009; 34: 897-903.
27. Ueda M, Terai Y, Yamashita Y, Kumagai K, Ueki K, Yamaguchi H, Akise D, Hung YC, Ueki M: Correlation between vascular endothelial growth factor-C expression and invasion phenotype in cervical carcinomas. Int J Cancer 2002;98:335-343. (Pubitemid 34188675)
28. Mitsuhashi A, Tanaka H, Tanaka N, Sugita M, Shirasawa H, Tokita H, Eda H, Sekiya S: Establishment and characterization of a new HPV-negative squamous cell carcinoma cell line (Yumoto) from the human uterine cervix. Gynecol Oncol 1998;70:339-347. (Pubitemid 28473632)
29. Narisawa-Saito M, Yoshimatsu Y, Ohno S, Yugawa T, Egawa N, Fujita M, Hirohashi S, Kiyono T: An in vitro multistep carcinogenesis model for human cervical cancer. Cancer Res 2008;68:5699-5705.
30. Mazzocca A, Coppari R, De Franco R, Cho JY, Libermann TA, Pinzani M, Toker A: A secreted form of ADAM9 promotes carcinoma invasion through tumor-stromal interactions. Cancer Res 2005;65:4728-4738. (Pubitemid 40740809)
31. Zubel A, Flechtenmacher C, Edler L, Alonso A: Expression of ADAM9 in CIN3 lesions and squamous cell carcinomas of the cervix. Gynecol Oncol 2009;114:332-336.
32. Weskamp G, Cai H, Brodie TA, Higashyama S, Manova K, Ludwig T, Blobel CP: Mice lacking the metalloprotease-disintegrin MDC9 (ADAM9) have no evident major abnormalities during development or adult life. Mol Cell Biol 2002;22:1537-1544. (Pubitemid 34150789)
33. Zigrino P, Steiger J, Fox JW, Löffek S, Schild A, Nischt R, Mauch C: Role of ADAM-9 dis-integrin-cysteine-rich domains in human keratinocyte migration. J Biol Chem 2007; 282:30785-30793. (Pubitemid 350035232)
34. O'Shea C, McKie N, Buggy Y, Duggan C, Hill AD, McDermott E, O'Higgins N, Duffy MJ: Expression of ADAM-9 mRNA and protein in human breast cancer. Int J Cancer 2003; 105:754-761. (Pubitemid 36706097)
35. Zigrino P, Mauch C, Fox JW, Nischt R: Adam-9 expression and regulation in human skin melanoma and melanoma cell lines. Int J Cancer 2005; 116:853-859. (Pubitemid 41209190)
36. Peduto L, Reuter VE, Shaffer DR, Scher HI, Blobel CP: Critical function for ADAM9 in mouse prostate cancer. Cancer Res 2005;65: 9312-9319. (Pubitemid 41507998)
37. Shintani Y, Higashiyama S, Ohta M, Hirabayashi H, Yamamoto S, Yoshimasu T, Matsuda H, Matsuura N: Overexpression of ADAM9 in non-small cell lung cancer correlates with brain metastasis. Cancer Res 2004;64:4190-4196. (Pubitemid 38802422)
38. Carl-McGrath S, Lendeckel U, Ebert M, Roessner A, Rocken C: The disintegrin-me-talloproteinases ADAM9, ADAM 12, and ADAM15 are upregulated in gastric cancer. Int J Oncol 2005;26:17-24.
39. Millichip M, Dallas D, Wu E, Dale S, McKie N: The metallo-disintegrin ADAM 10 (MADM) from bovine kidney has type IV collagenase activity in vitro. Biochem Biophys Res Commun 1998;245:594-598. (Pubitemid 28418550)
40. Franzke CW, Tasanen K, Schacke H, Zhou Z, Tryggvason K, Mauch C, Zigrino P, Sunnarborg S, Lee DC, Fahrenholz F, Bruckner-Tuderman L: Transmembrane collagen XVII, an epithelial adhesion protein, is shed from the cell surface by ADAMs. EMBO J 2002;21: 5026-5035.
41. Yamada T, Endo R, Tsukagoshi K, Fujita S, Honda K, Kinoshita M, Hasebe T, Hirohashi S: Aberrant expression of a hemidesmosomal protein, bullous pemphigoid antigen 2, in human squamous cell carcinoma. Lab Invest 1996;75:589-600. (Pubitemid 26346808)
42. McCulloch DR, Akl P, Samaratunga H, Herington AC, Odorico DM: Expression of the disintegrin metalloprotease, ADAM-10, in prostate cancer and its regulation by dihy-drotestosterone, insulin-like growth factor I, and epidermal growth factor in the prostate cancer cell model LNCaP. Clin Cancer Res 2004;10:314-323. (Pubitemid 38114194)
43. Ko SY, Lin SC, Wong YK, Liu CJ, Chang KW, Liu TY: Increase of disintergin metalloprotease 10 (ADAM10) expression in oral squamous cell carcinoma. Cancer Lett 2007;245: 33-43.
44. Rocks N, Paulissen G, Quesada Calvo F, Polette M, Gueders M, Munaut C, Foidart JM, Noel A, Birembaut P, Cataldo D: Expression of a disintegrin and metalloprotease (ADAM and ADAMTS) enzymes in human non-small-cell lung carcinomas (NSCLC). Br J Cancer 2006;94:724-730. (Pubitemid 43361905)
45. Fröhlich C, Albrechtsen R, Dyrskjot L, Rudkjaer L, Ørntoft TF, Wewer UM: Molecular profiling of ADAM 12 in human bladder cancer. Clin Cancer Res 2006;12:7359-7368. (Pubitemid 46095409)
46. Roy R, Wewer UM, Zurakowski D, Pories SE, Moses MA: ADAM 12 cleaves extracellular matrix proteins and correlates with cancer status and stage. J Biol Chem 2004;279: 51323-51330. (Pubitemid 40017878)
47. Rocks N, Estrella C, Paulissen G, Quesada-Calvo F, Gilles C, Guéders MM, Crahay C, Foidart JM, Gösset P, Noel A, Cataldo DD: The metalloproteinase ADAM-12 regulates bronchial epithelial cell proliferation and apoptosis. Cell Prolif 2008;41:988-1001.
48. Mori S, Tanaka M, Nanba D, Nishiwaki E, Ishiguro H, Higashiyama S, Matsuura N: PACSIN3 binds ADAM12/meltrin alpha and up-regulates ectodomain shedding of hepa-rin-binding epidermal growth factor-like growth factor. J Biol Chem 2003;278:46029-46034. (Pubitemid 37432752)
49. Yasui A, Matsuura K, Shimizu E, Hijiya N, Higuchi Y, Yamamoto S: Expression of splice variants of the human ADAM15 gene and strong interaction between the cytoplasmic domain of one variant and Src family proteins Lck and Hck. Pathobiology 2004;71: 185-192. (Pubitemid 38969876)
50. Edwards DR, Handsley MM, Pennington CJ: The ADAM metalloproteinases. Mol Aspects Med 2008;29:258-289.
51. Kveiborg M, Jacobsen J, Lee MH, Nagase H, Wewer UM, Murphy G: Selective inhibition of ADAM 12 catalytic activity through engineering of tissue inhibitor of metalloproteinase 2 (TIMP-2). Biochem J 2010;430:79-86.
52. Fedak PW, Moravec CS, McCarthy PM, Altamentova SM, Wong AP, Skrtic M, Verma S, Weisel RD, Li RK: Altered expression of disintegrin metalloproteinases and their inhibitor in human dilated cardiomyopathy. Circulation 2006;113:238-245.